These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 36031049)

  • 21. Interleukin-4 and interleukin-13 as possible therapeutic targets in systemic sclerosis.
    Gasparini G; Cozzani E; Parodi A
    Cytokine; 2020 Jan; 125():154799. PubMed ID: 31400638
    [TBL] [Abstract][Full Text] [Related]  

  • 22. T follicular helper-like cells contribute to skin fibrosis.
    Taylor DK; Mittereder N; Kuta E; Delaney T; Burwell T; Dacosta K; Zhao W; Cheng LI; Brown C; Boutrin A; Guo X; White WI; Zhu J; Dong H; Bowen MA; Lin J; Gao C; Yu L; Ramaswamy M; Gaudreau MC; Woods R; Herbst R; Carlesso G
    Sci Transl Med; 2018 Mar; 10(431):. PubMed ID: 29514998
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased frequency of Th17 cells in systemic sclerosis is related to disease activity and collagen overproduction.
    Yang X; Yang J; Xing X; Wan L; Li M
    Arthritis Res Ther; 2014 Jan; 16(1):R4. PubMed ID: 24398084
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulatory T Cells in Systemic Sclerosis: a Comprehensive Review.
    Slobodin G; Rimar D
    Clin Rev Allergy Immunol; 2017 Apr; 52(2):194-201. PubMed ID: 27318947
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cytokines in systemic sclerosis].
    Baraut J; Farge D; Jean-Louis F; Kesmandt H; Durant C; Verrecchia F; Michel L
    Pathol Biol (Paris); 2012 Apr; 60(2):127-39. PubMed ID: 20116938
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Systemic Sclerosis Dermal Fibroblasts Suppress Th1 Cytokine Production via Galectin-9 Overproduction due to Fli1 Deficiency.
    Saigusa R; Asano Y; Nakamura K; Hirabayashi M; Miura S; Yamashita T; Taniguchi T; Ichimura Y; Takahashi T; Yoshizaki A; Miyagaki T; Sugaya M; Sato S
    J Invest Dermatol; 2017 Sep; 137(9):1850-1859. PubMed ID: 28528914
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction of Inflammation and Fibrosis by Semaphorin 4A in Systemic Sclerosis.
    Carvalheiro T; Affandi AJ; Malvar-Fernández B; Dullemond I; Cossu M; Ottria A; Mertens JS; Giovannone B; Bonte-Mineur F; Kok MR; Marut W; Reedquist KA; Radstake TR; García S
    Arthritis Rheumatol; 2019 Oct; 71(10):1711-1722. PubMed ID: 31012544
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Th17 cell-derived miR-155-5p modulates interleukin-17 and suppressor of cytokines signaling 1 expression during the progression of systemic sclerosis.
    Han L; Lv Q; Guo K; Li L; Zhang H; Bian H
    J Clin Lab Anal; 2022 Jun; 36(6):e24489. PubMed ID: 35545753
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Involvement of B cells in the development of systemic sclerosis.
    Yoshizaki A; Fukasawa T; Ebata S; Yoshizaki-Ogawa A; Sato S
    Front Immunol; 2022; 13():938785. PubMed ID: 35967355
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The relationship between peripheral T follicular helper cells and disease severity in systemic sclerosis.
    Sahinoglu M; Sargin G; Yavasoglu I; Senturk T
    Clin Exp Med; 2024 Jan; 24(1):19. PubMed ID: 38280030
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mesenchymal stem cells (MSCs) from scleroderma patients (SSc) preserve their immunomodulatory properties although senescent and normally induce T regulatory cells (Tregs) with a functional phenotype: implications for cellular-based therapy.
    Cipriani P; Di Benedetto P; Liakouli V; Del Papa B; Di Padova M; Di Ianni M; Marrelli A; Alesse E; Giacomelli R
    Clin Exp Immunol; 2013 Aug; 173(2):195-206. PubMed ID: 23607751
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulatory T Cells in Systemic Sclerosis.
    Frantz C; Auffray C; Avouac J; Allanore Y
    Front Immunol; 2018; 9():2356. PubMed ID: 30374354
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased proportions of functionally impaired regulatory T cell subsets in systemic sclerosis.
    Ugor E; Simon D; Almanzar G; Pap R; Najbauer J; Németh P; Balogh P; Prelog M; Czirják L; Berki T
    Clin Immunol; 2017 Nov; 184():54-62. PubMed ID: 28522286
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interleukin-31 promotes fibrosis and T helper 2 polarization in systemic sclerosis.
    Kuzumi A; Yoshizaki A; Matsuda KM; Kotani H; Norimatsu Y; Fukayama M; Ebata S; Fukasawa T; Yoshizaki-Ogawa A; Asano Y; Morikawa K; Kazoe Y; Mawatari K; Kitamori T; Sato S
    Nat Commun; 2021 Oct; 12(1):5947. PubMed ID: 34642338
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Higher levels of serum interleukin-35 are associated with the severity of pulmonary fibrosis and Th2 responses in patients with systemic sclerosis.
    Tang J; Lei L; Pan J; Zhao C; Wen J
    Rheumatol Int; 2018 Aug; 38(8):1511-1519. PubMed ID: 29846790
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fli1-haploinsufficient dermal fibroblasts promote skin-localized transdifferentiation of Th2-like regulatory T cells.
    Saigusa R; Asano Y; Taniguchi T; Hirabayashi M; Nakamura K; Miura S; Yamashita T; Takahashi T; Ichimura Y; Toyama T; Yoshizaki A; Trojanowska M; Sato S
    Arthritis Res Ther; 2018 Feb; 20(1):23. PubMed ID: 29415756
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distinctive association of peripheral immune cell phenotypes with capillaroscopic microvascular patterns in systemic sclerosis.
    Kubo S; Nakayamada S; Miyazaki Y; Yoshikawa M; Yoshinari H; Satoh Y; Todoroki Y; Nakano K; Satoh M; Smith V; Cutolo M; Tanaka Y
    Rheumatology (Oxford); 2019 Dec; 58(12):2273-2283. PubMed ID: 31230071
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potential immunologic targets for treating fibrosis in systemic sclerosis: a review focused on leukocytes and cytokines.
    Hasegawa M; Takehara K
    Semin Arthritis Rheum; 2012 Dec; 42(3):281-96. PubMed ID: 22542279
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [B cell abnormalities and therapeutic strategies in systemic sclerosis].
    Yoshizaki A
    Nihon Rinsho Meneki Gakkai Kaishi; 2016; 39(3):197-206. PubMed ID: 27320935
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alteration of Th17 and Treg cell subpopulations co-exist in patients affected with systemic sclerosis.
    Fenoglio D; Battaglia F; Parodi A; Stringara S; Negrini S; Panico N; Rizzi M; Kalli F; Conteduca G; Ghio M; De Palma R; Indiveri F; Filaci G
    Clin Immunol; 2011 Jun; 139(3):249-57. PubMed ID: 21419712
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.